Antoine Francotte
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Development of a multiplex-based immunoassay for the characterization of diphtheria, tetanus and acellular pertussis antigens in human combined DTaP vaccines.
Journal: Journal of immunological methods
Published: December 12, 2022
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial.
Journal: PLOS global public health
Published: April 29, 2022
Regulation of Clostridium tetani Neurotoxin Expression by Culture Conditions.
Journal: Toxins
Published: November 29, 2021
Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 02, 2021
Development and validation of a targeted LC-MS/MS quantitation method to monitor cell culture expression of tetanus neurotoxin during vaccine production.
Journal: Talanta
Published: July 20, 2021
Characterisation of tetanus monoclonal antibodies as a first step towards the development of an in vitro vaccine potency immunoassay.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: January 19, 2021
Characterisation of diphtheria monoclonal antibodies as a first step towards the development of an in vitro vaccine potency immunoassay.
Journal: Biologicals : journal of the International Association of Biological Standardization
Published: September 15, 2020
The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind.
Journal: Drug testing and analysis
Published: September 12, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026